First Determination of the Heart-to-mediastinum Ratio Using Cardiac Dual Isotope (¹²³I-MIBG/⁹⁹mTc-tetrofosmin) CZT Imaging in Patients with Heart Failure: the ADRECARD Study
Overview
Nuclear Medicine
Radiology
Authors
Affiliations
Purpose: Cardiac innervation is assessed using the heart-to-mediastinum ratio (HMR) of metaiodobenzylguanidine (MIBG) on planar imaging using Anger single photon emission computed tomography (A-SPECT). The aim of the study was to determine the HMR of MIBG obtained using a CZT-based camera (D-SPECT; Spectrum Dynamics, Israel) in comparison with that obtained using conventional planar imaging.
Methods: The ADRECARD study prospectively evaluated 44 patients with heart failure. They underwent planar acquisition using the A-SPECT camera 4 h after (123)I-MIBG injection (236.4 ± 39.7 MBq). To localize the heart using D-SPECT, (99m)Tc-tetrofosmin (753 ± 133 MBq) was administered and dual isotope acquisition was performed using the D-SPECT system. HMR was calculated using both planar A-SPECT imaging and front view D-SPECT cine data. In a phantom study, we estimated a model fitting the A-SPECT and the D-SPECT data that was further applied to correct for differences between the cameras.
Results: A total of 44 patients (39 men and 5 women, aged 60 ± 11 years) with ischaemic (31 patients) and nonischaemic (13 patients) cardiomyopathy completed the study. Most patients (28 of 44) were NYHA class II, and the mean left ventricular ejection fraction was 33 ± 7 %. The mean HMR values were 1.34 ± 0.15 and 1.45 ± 0.27 from A-SPECT and D-SPECT, respectively (p < 0.0001). After correction, Lin's concordance correlation showed an almost perfect concordance between corrected D-SPECT HMR and A-SPECT HMR, and Bland-Altman analysis demonstrated a high agreement between the two measurements.
Conclusion: The ADRECARD study demonstrated that determination of late HMR during cardiac MIBG imaging using dual isotope ((123)I and (99m)Tc) acquisition on a CZT camera (D-SPECT) is feasible in patients with heart failure. A linear correction based on the phantom study yielded a high agreement between (123)I MIBG HMR obtained using a CZT camera and that from conventional planar imaging.
Sweet C, Shmuel N, Shoaf J, Stoecklein M, Muthukrishnan A, Stern E Nucl Med Mol Imaging. 2024; 58(1):1-8.
PMID: 38250182 PMC: 10796310. DOI: 10.1007/s13139-023-00825-2.
Yamashita S, Nakajima K, Okuda K, Yamamoto H, Shibutani T, Yoneyama T Ann Nucl Cardiol. 2023; 9(1):85-90.
PMID: 38058581 PMC: 10696155. DOI: 10.17996/anc.23-00003.
Current and potential roles of immuno-PET/-SPECT in CAR T-cell therapy.
Mulgaonkar A, Udayakumar D, Yang Y, Harris S, Oz O, Ramakrishnan Geethakumari P Front Med (Lausanne). 2023; 10:1199146.
PMID: 37441689 PMC: 10333708. DOI: 10.3389/fmed.2023.1199146.
Are nuclear medicine images quantified in 2D and 3D equally functional?.
Nakajima K, Shibutani T J Nucl Cardiol. 2023; 30(5):1968-1972.
PMID: 37156963 DOI: 10.1007/s12350-023-03290-8.
Mishkina A, Saushkin V, Atabekov T, Sazonova S, Shipulin V, Massalha S J Nucl Cardiol. 2022; 30(1):371-382.
PMID: 35834158 DOI: 10.1007/s12350-022-03046-w.